Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 4:10 pm Purchase |
2024-12-31 | 13G | Foxx Development Holdings Inc. FOXX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 640,057 8.100% |
640,057 (New Position) |
Filing History |
| 2025-02-10 5:06 pm Purchase |
2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3,633,333 9.200% |
3,633,333 (New Position) |
Filing History |
| 2025-02-10 5:04 pm Purchase |
2024-12-31 | 13G | BioAtla, Inc. BCAB |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7,349,205 9.900% |
7,349,205 (New Position) |
Filing History |
| 2025-02-07 4:17 pm Unchanged |
2024-12-31 | 13G | VELO3D INC VLDX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,187,056 0.600% |
0 (Unchanged) |
Filing History |
| 2025-02-07 4:16 pm Unchanged |
2024-12-31 | 13G | EQV Ventures Acquisition Corp. EQV |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,000 0.000% |
0 (Unchanged) |
Filing History |
| 2025-02-07 4:15 pm Purchase |
2024-12-31 | 13G | OnKure Therapeutics, Inc. OKUR |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 399,743 3.200% |
399,743 (New Position) |
Filing History |
| 2025-02-07 4:15 pm Sale |
2024-12-31 | 13G | Nutex Health, Inc. NUTX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-294,592 (Position Closed) |
Filing History |
| 2025-01-31 4:15 pm Purchase |
2024-12-31 | 13G | Horizon Space Acquisition II Corp. HSPTU |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 530,000 5.800% |
530,000 (New Position) |
Filing History |
| 2025-01-31 4:15 pm Purchase |
2024-12-31 | 13G | ASPAC III Acquisition Corp. ASPC |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 335,000 5.100% |
335,000 (New Position) |
Filing History |
| 2025-01-23 4:05 pm Sale |
2025-01-21 | 13D | VERTEX ENERGY INC VTNRQ |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-1,114,707 (Position Closed) |
Filing History |
| 2024-11-14 11:02 am Purchase |
2024-09-30 | 13G | Nutex Health, Inc. NUTX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 294,592 11.000% |
294,592 (New Position) |
Filing History |
| 2024-11-14 11:00 am Purchase |
2024-09-30 | 13G | Precision BioSciences, Inc. DTIL |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 406,250 5.300% |
406,250 (New Position) |
Filing History |
| 2024-11-14 10:31 am Purchase |
2024-09-30 | 13G | VELO3D INC VLDX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,187,056 9.900% |
1,187,056 (New Position) |
Filing History |
| 2024-11-14 10:30 am Purchase |
2024-09-30 | 13G | Melar Acquisition Corp. I MACI |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,485,000 9.300% |
1,485,000 (New Position) |
Filing History |
| 2024-11-14 10:11 am Purchase |
2024-09-30 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3,062,690 9.200% |
3,062,690 (New Position) |
Filing History |
| 2024-11-14 10:06 am Purchase |
2024-09-30 | 13G | Bakkt Holdings, Inc. BKKT |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 692,042 9.900% |
692,042 (New Position) |
Filing History |
| 2024-11-14 10:01 am Purchase |
2024-09-30 | 13G | BIORA THERAPEUTICS INC PAR BIORQ |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,958,480 9.990% |
19,958,480 (New Position) |
Filing History |
| 2024-11-08 09:01 am Purchase |
2024-09-30 | 13G | CompoSecure, Inc. CMPO |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 4,309,903 4.160% |
331,470 (+8.33%) |
Filing History |
| 2024-11-08 09:00 am Unchanged |
2024-09-30 | 13G | Capricor Therapeutics, Inc. CAPR |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,789,699 6.500% |
0 (Unchanged) |
Filing History |
| 2024-11-08 08:33 am Purchase |
2024-09-30 | 13G | SELLAS Life Sciences Group, Inc. SLS |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 13,264,712 9.900% |
11,184,658 (+537.71%) |
Filing History |